Skip to main content
. 2012 Mar 1;103(5):913–920. doi: 10.1111/j.1349-7006.2012.02231.x

Figure 3.

Figure 3

Clinical and pathological response to paclitaxel or P‐FEC. Comparison of clinical response to paclitaxel or P‐FEC between glutathione S‐transferase P1 (GSTP1)‐positive and GSTP1‐negative tumors in (A) estrogen receptor (ER)‐positive tumors and (B) ER‐negative tumors. Pathological response to paclitaxel or P‐FEC was also compared between GSTP1‐positive and GSTP1‐negative tumors in (C) ER‐positive tumors and (D) ER‐negative tumors. PAC, paclitaxel; P‐FEC, paclitaxel followed by combined 5‐ fluorouracil/epirubicin/cyclophosphamide; pCR, pathological complete response; −ve, negative; +ve, positive; bars, median.